Search

everythinglearnresearchcommunity

for

Search:↓

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

CTE and FPHL are different hair loss types with unique causes.

Hair loss causes stress and affects mental health; treatment and support needed.

Some people with chronic hair loss may have thyroid autoimmunity.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Albendazole may cause hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

The supplement improved hair health and reduced shedding in people with telogen effluvium.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Heavy metals might contribute to hair loss in Telogen Effluvium.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Post-COVID-19 hair loss is likely due to stress and inflammation.

The cytokine and peptide serum was most effective in reducing hair loss and improving hair growth.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Weight loss can cause temporary hair loss, especially in women and older adults.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.